One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133⁺ Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction

Table 1

Demographic and clinical characteristics. BMI indicates body mass index, CAD coronary artery disease, PCI percutaneous coronary intervention, CK creatinine kinase, and CK-MB creatine kinase-muscle and brain.

Age (yrs)	52,2±8.9
Male (%)	90
BMI	28±5.7
Diabetes (%)	15
Hypertension (%)	35
Hyperlipidemia (%)	20
Smoking (%)	70
Family history of CAD (%)	15
Door to balloon (Min)	123.6±97.4
PCI to injection (days)	6.4±2.2
Killip class	I: 95; II: 5
Maximal ST elevation (mm)	11.2±5.5
Q waves on admission (%)	55
Peak troponin T (UI/mL)	10.48±8.34
Peak CK (UI/mL)	2744±2193
Peak CK-MB (UI/mL)	341±260.7